|
May 14
|
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
|
|
Apr 22
|
Bausch Health Learns Icahn Has 34% Economic Interest in Shares
|
|
Apr 22
|
April 2025's Top Growth Stocks With Strong Insider Ownership
|
|
Apr 22
|
Bausch Health Announces Filing of Supplement to Proxy Statement
|
|
Apr 21
|
Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?
|
|
Apr 19
|
Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in?
|
|
Apr 18
|
3 Reasons to Sell BLCO and 1 Stock to Buy Instead
|
|
Apr 17
|
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
|
|
Mar 15
|
Bausch Health announces next steps in financining initiative
|
|
Mar 14
|
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
|
|
Mar 1
|
Bausch Health Companies Inc. (BHC): Among Top Stock Picks From Carl Icahn’s Portfolio
|
|
Feb 28
|
Bausch Health Plans $5 Billion Debt Sale to Tackle Liabilities
|
|
Feb 27
|
Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?
|
|
Feb 16
|
Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability
|
|
Feb 14
|
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
|
|
Feb 12
|
Earnings Preview: Bausch Health (BHC) Q4 Earnings Expected to Decline
|
|
Feb 10
|
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
|
|
Dec 12
|
Contact lens maker Bausch + Lomb says it is exploring sale
|
|
Dec 12
|
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
|
|
Dec 12
|
Eye health company Bausch + Lomb’s affiliate acquires Elios Vision
|